drugset / Trial / NCT04027751

The Efficacy and Safety of Tropisetron in Preventing Emergence Delirium

NCT04027751

Phase 4 Unknown 1508 enrolled Beijing Chao Yang Hospital
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to determine the efficacy and safety of Tropisetron in preventing emergence delirium.

Timeline

Start
2019-08-01
Primary completion
2021-12-31
Completion
2022-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Tropisetron Small molecule 5 mg Intravenous

Indications